Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 524067, 9 pages
http://dx.doi.org/10.1155/2011/524067
Review Article

Contributions of Cytogenetics and Molecular Cytogenetics to the Diagnosis of Adipocytic Tumors

Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan

Received 5 September 2010; Accepted 15 December 2010

Academic Editor: Brynn Levy

Copyright © 2011 Jun Nishio. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. A. Sandberg, Z. Gibas, and E. Saren, “Chromosome abnormalities in two benign adipose tumors,” Cancer Genetics and Cytogenetics, vol. 22, no. 1, pp. 55–61, 1986. View at Google Scholar · View at Scopus
  2. C. Turc-Carel, P. Dal Cin, and U. Rao, “Cytogenetic studies of adipose tissue tumors. I. A benign lipoma with reciprocal translocation t(3;12) (q28;q14),” Cancer Genetics and Cytogenetics, vol. 23, no. 4, pp. 283–289, 1986. View at Google Scholar · View at Scopus
  3. S. Heim, N. Mandahl, and U. Kristoffersson, “Reciprocal translocation t(3;12) (q27;q13) in lipoma,” Cancer Genetics and Cytogenetics, vol. 23, no. 4, pp. 301–304, 1986. View at Google Scholar · View at Scopus
  4. C. D. M. Fletcher, K. K. Unni, and F. Mertens, Pathology and Genetics of Tumours of Soft Tissue and Bone, World Health Organization Classification of Tumours, IARC Press, Lyon, France, 2002.
  5. J. A. Bridge, “Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms,” Journal of Orthopaedic Science, vol. 13, no. 3, pp. 273–282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. Tanas and J. R. Goldblum, “Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: a review,” Advances in Anatomic Pathology, vol. 16, no. 6, pp. 383–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Kearney, “Multiplex-FISH (M-FISH): technique, developments and applications,” Cytogenetic and Genome Research, vol. 114, no. 3-4, pp. 189–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kallioniemi, O. P. Kallioniemi, D. Sudar et al., “Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors,” Science, vol. 258, no. 5083, pp. 818–821, 1992. View at Google Scholar · View at Scopus
  9. D. Pinkel, R. Segraves, D. Sudar et al., “High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays,” Nature Genetics, vol. 20, no. 2, pp. 207–211, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Sandberg, “Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipoma,” Cancer Genetics and Cytogenetics, vol. 150, no. 2, pp. 93–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Hameed, “Pathology and genetics of adipocytic tumors,” Cytogenetic and Genome Research, vol. 118, no. 2-4, pp. 138–147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. W. Weiss and J. R. Goldblum, Enzinger and Weiss's Soft Tissue Tumors, Mosby, Philadelphia, Pa, USA, 15th edition, 2008.
  13. H. Willén, M. Åkerman, P. Dal Cin et al., “Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP study group,” Cancer Genetics and Cytogenetics, vol. 102, no. 1, pp. 46–49, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Bartuma, K. H. Hallor, I. Panagopoulos et al., “Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype,” Genes Chromosomes and Cancer, vol. 46, no. 6, pp. 594–606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. R. Petit, R. Mols, E. F. P. M. Schoenmakers, N. Mandahl, and W. J. M. Van De Ven, “LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family,” Genomics, vol. 36, no. 1, pp. 118–129, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Broberg, M. Zhang, B. Strömbeck et al., “Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15,” International Journal of Oncology, vol. 21, no. 2, pp. 321–326, 2002. View at Google Scholar · View at Scopus
  17. M. Nilsson, F. Mertens, M. Höglund, N. Mandahl, and I. Panagopoulos, “Truncation and fusion of HMGA2 in lipomas with rearrangements of 5q32→q33 and 12q14→q15,” Cytogenetic and Genome Research, vol. 112, no. 1-2, pp. 60–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Nilsson, I. Panagopoulos, F. Mertens, and N. Mandahl, “Fusion of the HMGA2 and NFIB genes in lipoma,” Virchows Archiv, vol. 447, no. 5, pp. 855–858, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Italiano, N. Ebran, R. Attias et al., “NFIB rearrangement in superficial, retroperitoneal, and colonic lipomas with aberrations involving chromosome band 9p22,” Genes Chromosomes and Cancer, vol. 47, no. 11, pp. 971–977, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. R. Petit, E. F. P. M. Schoenmakers, C. Huysmans, J. M. W. Geurts, N. Mandahl, and W. J. M. Van De Ven, “LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes,” Genomics, vol. 57, no. 3, pp. 438–441, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Bartuma, I. Panagopoulos, A. Collin et al., “Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups,” Molecular Cancer, vol. 8, article 36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Wang, R. L. Hulshizer, M. R. Erickson-Johnson et al., “Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3′ UTR is not critical for HMGA2 transcriptional upregulation,” Genes Chromosomes and Cancer, vol. 48, no. 8, pp. 673–678, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Dahlén, M. Debiec-Rychter, F. Pedeutour et al., “Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors,” International Journal of Cancer, vol. 103, no. 5, pp. 616–623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Wang, R. Q. Zamolyi, H. Zhang et al., “Fusion of HMGA1 to the LPP/TPRG1 intergenic region in a lipoma identified by mapping paraffin-embedded tissues,” Cancer Genetics and Cytogenetics, vol. 196, no. 1, pp. 64–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Szymanska, M. Virolainen, M. Tarkkanen et al., “Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study,” Cancer Genetics and Cytogenetics, vol. 99, no. 1, pp. 14–18, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Gisselsson, H. A. Domanski, M. Höglund et al., “Unique cytological features and chromosome aberrations in chondroid lipoma: a case report based on fine-needle aspiration cytology, histopathology, electron microscopy, chromosome banding, and molecular cytogenetics,” American Journal of Surgical Pathology, vol. 23, no. 10, pp. 1300–1304, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. T. A. Thomson, D. Horsman, and T. C. Bainbridge, “Cytogenetic and cytologic features of chondroid lipoma of soft tissue,” Modern Pathology, vol. 12, no. 1, pp. 88–91, 1999. View at Google Scholar · View at Scopus
  28. F. Ballaux, M. Debiec-Rychter, I. De Wever, and R. Sciot, “Chondroid lipoma is characterized by t(11;16)(q13;p12-13),” Virchows Archiv, vol. 444, no. 2, pp. 208–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Huang, J. Sumegi, P. D. Cin et al., “C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma,” Genes Chromosomes and Cancer, vol. 49, no. 9, pp. 810–818, 2010. View at Publisher · View at Google Scholar
  30. N. Mandahl, F. Mertens, H. Willen, A. Rydholm, O. Brosjo, and F. Mitelman, “A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas,” Journal of Cancer Research and Clinical Oncology, vol. 120, no. 12, pp. 707–711, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. C. D. M. Fletcher, M. Akerman, P. Dal Cin et al., “Correlation between clinicopathological features and karyotype in lipomatous tumors: a report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group,” American Journal of Pathology, vol. 148, no. 2, pp. 623–630, 1996. View at Google Scholar · View at Scopus
  32. P. D. Cin, R. Sciot, P. Polito et al., “Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas,” Histopathology, vol. 31, no. 3, pp. 222–225, 1997. View at Google Scholar · View at Scopus
  33. D. Gisselsson, M. Höglund, F. Mertens, P. Dal Cin, and N. Mandahl, “Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type region: metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics,” American Journal of Pathology, vol. 155, no. 1, pp. 61–66, 1999. View at Google Scholar · View at Scopus
  34. G. Maire, A. Forus, C. Foa et al., “11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5,” Genes Chromosomes and Cancer, vol. 37, no. 4, pp. 389–395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Gisselsson, M. K. Hibbard, P. Dal Cin et al., “PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms,” American Journal of Pathology, vol. 159, no. 3, pp. 955–962, 2001. View at Google Scholar · View at Scopus
  36. P. Brandal, B. Bjerkehagen, and S. Heim, “Rearrangement of chromosomal region 8q11-13 in lipomatous tumours: correlation with lipoblastoma morphology,” Journal of Pathology, vol. 208, no. 3, pp. 388–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Bartuma, H. A. Domanski, F. V. Von Steyern, C. M. Kullendorff, N. Mandahl, and F. Mertens, “Cytogenetic and molecular cytogenetic findings in lipoblastoma,” Cancer Genetics and Cytogenetics, vol. 183, no. 1, pp. 60–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. M. Coffin, A. Lowichik, and A. Putnam, “Lipoblastoma (LPB): a clinicopathologic and immunohistochemical analysis of 59 cases,” American Journal of Surgical Pathology, vol. 33, no. 11, pp. 1705–1712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Meloni-Ehrig, L. Riggott, N. C. Christacos, P. N. Mowrey, and J. Johal, “A case of lipoblastoma with seven copies of chromosome 8,” Cancer Genetics and Cytogenetics, vol. 190, no. 1, pp. 49–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. K. Hibbard, H. P. Kozakewich, P. Dal Cin et al., “PLAG1 fusion oncogenes in lipoblastoma,” Cancer Research, vol. 60, no. 17, pp. 4869–4872, 2000. View at Google Scholar · View at Scopus
  41. R. Sciot, I. De Wever, and M. Debiec-Rychter, “Lipoblastoma in a 23-year-old male: distinction from atypical lipomatous tumor using cytogenetic and fluorescence in-situ hybridization analysis,” Virchows Archiv, vol. 442, no. 5, pp. 468–471, 2003. View at Google Scholar · View at Scopus
  42. A. Röpke, T. Kalinski, U. Kluba, U. Von Falkenhausen, P. F. Wieacker, and M. Röpke, “PLAG1 activation in lipoblastoma coinciding with low-level amplification of a derivative chromosome 8 with a deletion del(8)(q13q21.2),” Cytogenetic and Genome Research, vol. 119, no. 1-2, pp. 33–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. N. De Saint Aubain Somerhausen, J. M. Coindre, M. Debiec-Rychter, J. Delplace, and R. Sciot, “Lipoblastoma in adolescents and young adults: report of six cases with FISH analysis,” Histopathology, vol. 52, no. 3, pp. 294–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Sciot, M. Akerman, P. Dal Cin et al., “Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas: a report of the CHAMP study group,” American Journal of Surgical Pathology, vol. 21, no. 4, pp. 441–444, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. B. De Jong, S. M. M. J. Castedo, J. W. Oosterhuis, and A. Dam, “Trisomy 7 in a case of angiomyolipoma,” Cancer Genetics and Cytogenetics, vol. 34, no. 2, pp. 219–222, 1988. View at Google Scholar · View at Scopus
  46. M. Debiec-Rychter, H. Saryusz-Wolska, and M. Salagierski, “Cytogenetic analysis of renal angiomyolipoma,” Genes Chromosomes and Cancer, vol. 4, no. 1, pp. 101–103, 1992. View at Google Scholar · View at Scopus
  47. B. Wullich, W. Henn, S. Siemer, G. Seitz, A. Freiler, and K. D. Zang, “Clonal chromosome aberrations in three of five sporadic angiomyolipomas of the kidney,” Cancer Genetics and Cytogenetics, vol. 96, no. 1, pp. 42–45, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Dal Cin, R. Sciot, H. Van Poppel, L. Baert, B. Van Damme, and H. Van Den Berghe, “Chromosome analysis in angiomyolipoma,” Cancer Genetics and Cytogenetics, vol. 99, no. 2, pp. 132–134, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Dal Cin, N. C. Gutierrez, J. M. Hernandez, and H. Van Den Berghe, “Molecular cytogenetics in angiomyolipomas,” Cancer Genetics and Cytogenetics, vol. 106, no. 2, p. 182, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. M. M. Kattar, D. J. Grignon, J. N. Eble et al., “Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridization: evidence for clonal origin,” Human Pathology, vol. 30, no. 3, pp. 295–299, 1999. View at Google Scholar · View at Scopus
  51. K. C. Chang, P. I. Chen, Z. H. Huang, Y. M. Lin, and P. L. Kuo, “Adrenal myelolipoma with translocation (3;21)(q25;p11),” Cancer Genetics and Cytogenetics, vol. 134, no. 1, pp. 77–80, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Mandahl, F. Mertens, H. Willén, A. Rydholm, A. Kreicbergs, and F. Mitelman, “Nonrandom pattern of telomeric associations in atypical lipomatous tumors with ring and giant marker chromosomes,” Cancer Genetics and Cytogenetics, vol. 103, no. 1, pp. 25–34, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. P. D. Cin, P. Kools, R. Sciot et al., “Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors,” Cancer Genetics and Cytogenetics, vol. 68, no. 2, pp. 85–90, 1993. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Pedeutour, R. F. Suijkerbuijk, J. Van Gaal et al., “Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma,” Cancer Genetics and Cytogenetics, vol. 66, no. 2, pp. 133–134, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Pedeutour, R. F. Suijkerbuijk, A. Forus et al., “Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma,” Genes Chromosomes and Cancer, vol. 10, no. 2, pp. 85–94, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Szymanska, M. Tarkkanen, T. Wiklund et al., “Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization,” Genes Chromosomes and Cancer, vol. 15, no. 2, pp. 89–94, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Pedeutour, A. Forus, J. M. Coindre et al., “Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors,” Genes Chromosomes and Cancer, vol. 24, no. 1, pp. 30–41, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. A. P. Dei Tos, C. Doglioni, S. Piccinin et al., “Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours,” Journal of Pathology, vol. 190, no. 5, pp. 531–536, 2000. View at Google Scholar · View at Scopus
  59. F. Micci, M. R. Teixeira, B. Bjerkehagen, and S. Heim, “Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH,” Cytogenetic and Genome Research, vol. 97, no. 1-2, pp. 13–19, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Italiano, L. Bianchini, F. Keslair et al., “HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon,” International Journal of Cancer, vol. 122, no. 10, pp. 2233–2241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Trombetta, F. Mertens, A. Lonoce et al., “Characterization of a hotspot region on chromosome 12 for amplification in ring chromosomes in atypical lipomatous tumors,” Genes Chromosomes and Cancer, vol. 48, no. 11, pp. 993–1001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. M. R. Erickson-Johnson, A. R. Seys, C. W. Roth et al., “Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma,” Modern Pathology, vol. 22, no. 12, pp. 1541–1547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Nilsson, L. A. Meza-Zepeda, F. Mertens, A. Forus, O. Myklebost, and N. Mandahl, “Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas,” International Journal of Cancer, vol. 109, no. 3, pp. 363–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Sirvent, J. M. Coindre, G. Maire et al., “Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR,” American Journal of Surgical Pathology, vol. 31, no. 10, pp. 1476–1489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Weaver, E. Downs-Kelly, J. R. Goldblum et al., “Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms,” Modern Pathology, vol. 21, no. 8, pp. 943–949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Weaver, P. Rao, J. R. Goldblum et al., “Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?” Modern Pathology, vol. 23, no. 10, pp. 1301–1306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. W. H. Henricks, Y. C. Chu, J. R. Goldblum, and S. W. Weiss, “Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation,” American Journal of Surgical Pathology, vol. 21, no. 3, pp. 271–281, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Elgar and J. R. Goldblum, “Well-differentiated liposarcoma of the retroperitoneum: a clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation,” Modern Pathology, vol. 10, no. 2, pp. 113–120, 1997. View at Google Scholar · View at Scopus
  69. D. Gisselsson, M. Höglund, F. Mertens et al., “The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells,” Human Genetics, vol. 104, no. 4, pp. 315–325, 1999. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Nishio, H. Iwasaki, M. Ishiguro et al., “Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization,” International Journal of Oncology, vol. 22, no. 3, pp. 535–542, 2003. View at Google Scholar · View at Scopus
  71. F. Chibon, O. Mariani, J. Derré et al., “A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas,” Cancer Genetics and Cytogenetics, vol. 139, no. 1, pp. 24–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. R. J. Rieker, S. Joos, C. Bartsch et al., “Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas,” International Journal of Cancer, vol. 99, no. 1, pp. 68–73, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. I. Hostein, J. M. Coindre, J. Derré, O. Mariani, F. Chibon, and A. Aurias, “Comparative genomic hybridization study of paraffin-embedded dedifferentiated liposarcoma fixed with Holland Bouin's fluid,” Diagnostic Molecular Pathology, vol. 12, no. 3, pp. 166–173, 2003. View at Google Scholar · View at Scopus
  74. O. Mariani, C. Brennetot, J. M. Coindre et al., “JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas,” Cancer Cell, vol. 11, no. 4, pp. 361–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Chibon, O. Mariani, J. Derré et al., “ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14q-q15 and 6q23 amplifications,” Genes Chromosomes and Cancer, vol. 40, no. 1, pp. 32–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. A. A. Sandberg, “Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma,” Cancer Genetics and Cytogenetics, vol. 155, no. 1, pp. 1–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Turc-Carel, J. Limon, and P. Dal Cin, “Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16) (q13;p11) in myxoid liposarcomas,” Cancer Genetics and Cytogenetics, vol. 23, no. 4, pp. 291–299, 1986. View at Google Scholar · View at Scopus
  78. C. Sreekantaiah, C. P. Karakousis, S. P. L. Leong, and A. A. Sandberg, “Cytogenetic findings in liposarcoma correlate with histopathologic subtypes,” Cancer, vol. 69, no. 10, pp. 2484–2495, 1992. View at Google Scholar · View at Scopus
  79. B. P. Rubin and P. Dal Cin, “The genetics of lipomatous tumors,” Seminars in Diagnostic Pathology, vol. 18, no. 4, pp. 286–293, 2001. View at Google Scholar · View at Scopus
  80. H. Iwasaki, K. Nabeshima, J. Nishio et al., “Pathology of soft-tissue tumors: daily diagnosis, molecular cytogenetics and experimental approach,” Pathology International, vol. 59, no. 8, pp. 501–521, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. I. Panagopoulos, M. Höglund, F. Mertens, N. Mandahl, F. Mitelman, and P. Åman, “Fusion of the EWS and CHOP genes in myxoid liposarcoma,” Oncogene, vol. 12, no. 3, pp. 489–494, 1996. View at Google Scholar · View at Scopus
  82. I. Panagopoulos, C. Lassen, M. Isaksson, F. Mitelman, N. Mandahl, and P. Åman, “Characteristics sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia,” Oncogene, vol. 15, no. 11, pp. 1357–1362, 1997. View at Google Scholar · View at Scopus
  83. P. Dal Cin, R. Sciot, I. Panagopoulos et al., “Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features,” Journal of Pathology, vol. 182, no. 4, pp. 437–441, 1997. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Mrozek and C. D. Bloomfield, “Der(16)t(1;16) is a secondary chromosome aberration in at least eighteen different types of human cancer,” Genes Chromosomes and Cancer, vol. 23, no. 1, pp. 78–80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. Z. Gibas, M. Miettinen, J. Limon et al., “Cytogenetic and immunohistochemical profile of myxoid liposarcoma,” American Journal of Clinical Pathology, vol. 103, no. 1, pp. 20–26, 1995. View at Google Scholar · View at Scopus
  86. N. C. Birch, C. R. Antonescu, M. Nelson et al., “Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16),” Journal of Molecular Diagnostics, vol. 5, no. 3, pp. 191–194, 2003. View at Google Scholar · View at Scopus
  87. E. Downs-Kelly, J. R. Goldblum, R. M. Patel et al., “The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms,” American Journal of Surgical Pathology, vol. 32, no. 1, pp. 8–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Parente, J. Grosgeorge, J. M. Coindre, P. Terrier, O. Vilain, and C. Turc-Carel, “Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors,” Cancer Genetics and Cytogenetics, vol. 115, no. 2, pp. 89–95, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Schmidt, F. Bartel, M. Kappler et al., “Gains of 13q are correlated with a poor prognosis in liposarcoma,” Modern Pathology, vol. 18, no. 5, pp. 638–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Ohguri, M. Hisaoka, S. Kawauchi et al., “Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation,” Journal of Clinical Pathology, vol. 59, no. 9, pp. 978–983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Mertens, C. D. M. Fletcher, P. Dal Cin et al., “Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the champ study group,” Genes Chromosomes and Cancer, vol. 22, no. 1, pp. 16–25, 1998. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Sugita, K. Seki, K. Yokozawa et al., “Analysis of CHOP rearrangement in pleomorphic liposarcomas using fluorescence in situ hybridization,” Cancer Science, vol. 100, no. 1, pp. 82–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Forus, D. O. Weghuis, D. Smeets, O. Fodstad, O. Myklebost, and A. G. Van Kessel, “Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas,” Genes Chromosomes and Cancer, vol. 14, no. 1, pp. 8–14, 1995. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Popov, M. Virolainen, E. Tukiainen et al., “Primary soft tissue sarcoma and its local recurrence: genetic changes studied by comparative genomic hybridization,” Modern Pathology, vol. 14, no. 10, pp. 978–984, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. R. S. de Vreeze, D. de Jong, W. Koops et al., “Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis,” International Journal of Cancer, vol. 128, no. 4, pp. 778–786, 2011. View at Google Scholar
  96. R. Schneider-Stock, H. Walter, K. Radig et al., “MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas,” Journal of Cancer Research and Clinical Oncology, vol. 124, no. 10, pp. 532–540, 1998. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Mentzel, G. Palmedo, M. Hantschke, J. Woziwodzki, and C. Beck, “Mixed-type liposarcoma: clinicopathological, immunohistochemical, and molecular analysis of a case arising in deep soft tissues of the lower extremity,” Virchows Archiv, vol. 453, no. 2, pp. 197–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Zhang, M. Erickson-Johnson, X. Wang et al., “Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors,” American Journal of Surgical Pathology, vol. 34, no. 9, pp. 1304–1311, 2010. View at Publisher · View at Google Scholar